Cytek Biosciences, Inc. Common Stock

Cytek Biosciences, Inc. Common Stock

Compare this stock

CTKB Stock Report Card

$

VolatilityTechnicalsProfitPerformanceEarnings

38%

Performance

Score:

10/100

CTKB returned -67.30% in the last 12 months. Based on SPY's performance of 9.73%, its performance is below average giving it a score of 10 of 100.

Technicals

Score:

46/100

CTKB receives a 46 of 100 based on 14 indicators. 6 are bullish, 7 are bearish.

Earnings

Score:

43/100

CTKB has missed earnings 2 times in the last 20 quarters.

Profit

Score:

38/100

Out of the last 15 quarters, CTKB has had 8 profitable quarters and has increased their profits year over year on 2 of them.

Volatility

Score:

49/100

CTKB has had a lower than average amount of volatility over the last 12 months giving it a score of 49 of 100.

Cytek Biosciences, Inc. Common Stock Summary

Nasdaq / CTKB
Healthcare
Medical - Devices
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.